Literature DB >> 10460453

Remission of AIDS-associated progressive multifocal leukoencephalopathy after cidofovir therapy.

A M Brambilla, A Castagna, R Novati, P Cinque, M R Terreni, M C Moioli, A Lazzarin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10460453     DOI： 10.1007/s004150050440

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  9 in total

1.  Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: extended follow-up of an observational study.

Authors:  A De Luca; M L Giancola; A Ammassari; S Grisetti; A Cingolani; D Larussa; L Alba; R Murri; G Ippolito; R Cauda; A Monforte; A Antinori
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

Review 2.  Designs for clinical trials to test the efficacy of therapeutics in progressive multifocal leukoencephalopathy.

Authors:  C T Yiannoutsos; A De Luca
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

3.  Progressive Multifocal Leukoencephalopathy.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-07       Impact factor: 3.598

Review 4.  Progressive multifocal leukoencephalopathy and other forms of JC virus disease.

Authors:  Bruce J Brew; Nicholas W S Davies; Paola Cinque; David B Clifford; Avindra Nath
Journal:  Nat Rev Neurol       Date:  2010-12       Impact factor: 42.937

5.  Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring.

Authors:  J Gasnault; P Kousignian; M Kahraman; J Rahoiljaon; S Matheron; J F Delfraissy; Y Taoufik
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

Review 6.  Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.

Authors:  Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

7.  Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy.

Authors:  W Royal; B Dupont; D McGuire; L Chang; K Goodkin; T Ernst; M J Post; D Fish; G Pailloux; H Poncelet; M Concha; L Apuzzo; E Singer
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

Review 8.  Central nervous system infections in individuals with HIV-1 infection.

Authors:  Arunima Mamidi; Joseph A DeSimone; Roger J Pomerantz
Journal:  J Neurovirol       Date:  2002-06       Impact factor: 2.643

9.  Progressive Multifocal Leukoencephalopathy.

Authors:  Anna R. Thorner; Joel T. Katz
Journal:  Curr Infect Dis Rep       Date:  2001-08       Impact factor: 3.663
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.